Our programs are designed not just for immediate results, but for creating long-term health improvements and habits
However, one study found that headaches occurred slightly more often in people taking tirzepatide than the placebo: 9.4% of people taking Zepbound or Mounjaro reported headache, compared to 7.5% taking a placebo
CBS Sports
Klinic simplifies the process
Buckley ST, Bkdal TA, Vegge A, Maarbjerg SJ, Pyke C, Ahnfelt-Rnne J, Madsen KG, Schele SG, Alanentalo T, Kirk RK, Pedersen BL, Skyggebjerg RB, Benie AJ, Strauss HM, Wahlund PO, Bjerregaard S, Farkas E, Fekete C, Sndergaard FL, Borregaard J, Hartoft-Nielsen ML, Knudsen LB
doi: 10.1016/j.biomaterials.2025.123323 44 GaoW.LinW.TianM.FanS.EdwardsS.TranJ.et al